
Search
Selected Filter
Filter Results
Displaying 11–20 of 56 podcasts results
-
Dec 6, 2024
Eye on the Cure Podcast | Episode 77: Dr. Bob Bell
Dr. Bell, the CSO of Ascidian Therapeutics, talks about STELLAR, the company’s Phase ½ clinical trial for its emerging RNA-rewriting therapy for Stargardt disease (ABCA4 mutations).
-
Nov 15, 2024
Eye on the Cure Podcast | Episode 76: The Lemay-Pelletier Family
When the Lemay-Pelletier family from Montreal learned that three of their four children were losing vision from retinitis pigmentosa, they made the bold decision to spend 15 months traveling the world to give their kids as many visual memories as possible.
-
Oct 25, 2024
Eye on the Cure Podcast | Episode 75: Sharon King
Sharon King, co-founder and president of Taylor’s Tale, talks to host Ben Shaberman about her family’s journey when her daughter Taylor was diagnosed with Batten disease.
-
Oct 11, 2024
Eye on the Cure Podcast | Episode 74: Dr. Kia Washington
Dr. Kia Washington talks about her work in whole eye transplantation and more.
-
Sep 20, 2024
Eye on the Cure Podcast | Episode 73: Dr. Zuhal Butuner
Dr. Zuhal Butuner talks about her company’s two emerging RNA therapies for LCA10 and USH2A.
-
Aug 23, 2024
Eye on the Cure Podcast | Episode 72: Hannah Scanga
Hannah Scanga talks about the basics of genetic testing and counseling, and more.
-
Aug 9, 2024
Eye on the Cure Podcast | Episode 71: Dr. Leonide Saad
Dr. Saad discusses an emerging therapy for Stargardt disease that has performed well in clinical trials.
-
Jul 26, 2024
Eye on the Cure Podcast | Episode 70: Karen Petrou
Karen Petrou, the new board chair at the Foundation, talks to host Ben Shaberman about her vision for the Foundation moving forward. Karen has been an active director on the Foundation’s board for nearly two decades. She is co-founder and managing partner of Federal Financial Analytics, a firm providing analytical and advisory services on legislative, regulatory, and public-policy issues affecting financial services companies. Karen has RP and lives in Washington, DC, with her guide dog, Ike.
-
Jul 12, 2024
Eye on the Cure Podcast | Episode 69: Dr. Francois Paquet-Durand
Francois Paquet-Durand, PhD, a professor from the University of Tübingen and co-founder of the company Mireca, talks to host Ben Shaberman about the long journey of an emerging, Foundation-funded drug for the treatment of certain forms of retinitis pigmentosa. The episode highlights the challenges that scientists often encounter when developing a drug for a retinal disease, and the persistence and tenacity that are required to keep it moving forward.
-
Jun 28, 2024
Eye on the Cure Podcast | Episode 68: Dr. Michael Telias
For this episode of Eye on the Cure, Michael Telias, PhD, an assistant professor at the University of Rochester in New York, talks with host Ben Shaberman about forthcoming clinical trials to evaluate the FDA-approved drug disulfiram (aka, Antabuse) for improving vision in people with retinitis pigmentosa and other retinal diseases. Disulfiram was originally developed to deter people from abusing alcohol.